Pfizer is acquiring Vicuron Pharmaceuticals, a company that is dedicated to novel anti-infectives for both hospital-based and community-acquired infections. Along with this conmpany comes two drugs used for fighting fungus and bacteria. They are called Anidulafungin and Dalbavancin, and they are both currently under New Drug Application (NDA) at the FDA. "By acquiring Vicuron, we can help bring two very important new medicines to patients around the world," said Pfizer chairman and CEO Hank McKinnell.
latest ebusiness news. 
No comments yet. Be the first to comment!